2 in 1

Manufacturer
LIDL US LLC | Apollo Health and Beauty Care
Effective date
2022-09-12
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 23:50:39

Label at a glance#

Product2 in 1
Active ingredientPYRITHIONE ZINC
Label structure8 sections

Indications and uses

To prevent recurrence of flaking and itching associated with dandruff.

Dosage and administration

For best resuts, use at least twice a week or as directed by a doctor. For maximum dandruff control, use every time you shampoo. Wet hair, massage onto scalp and rinse. Repeat if desired.

Storage and handling

Store at room temperature

Label contents#

Full prescribing information#

Active Ingredient.

OTC - ACTIVE INGREDIENT SECTION

PYRITHIONE ZINC (1%)

Purpose

OTC - PURPOSE SECTION

Anti dandruff

Uses

INDICATIONS & USAGE SECTION

To prevent recurrence of flaking and itching associated with dandruff.

Warnings

WARNINGS SECTION

For external use only

When using this product

OTC - WHEN USING SECTION

Avoid contact with eyes.If contact occurs, rinse eyes thoroughly with water.

Stop use and ask a doctor

OTC - STOP USE SECTION

if condition worsens or does not improve after regular use of this product as directed.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • For best resuts, use at least twice a week or as directed by a doctor.
  • For maximum dandruff control, use every time you shampoo.
  • Wet hair, massage onto scalp and rinse. Repeat if desired.

Other Information

STORAGE AND HANDLING SECTION

Store at room temperature

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Water (Aqua), Sodium Laureth Sulfate, Sodium Chloride, Acrylates Copolymer, Glycol Distearate, Cocamidopropyl Betaine, Laureth-4, Dimethicone, Fragrance (Parfum), Cocamide MEA, Guar Hydroxypropyltrmonium Chloride, Sodium Hydroxide, Tetrasodium EDTA, Methylchloroisothiazolinone, Methylisothiazolinone, Blue 1 (Cl 42090), Red 33 (Cl 17200).

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

PP04PP04

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
209884zinc pyrithione 1 % Medicated ShampooPSN2
209884zinc pyrithione 10 MG/ML Medicated ShampooSCD2
209884zinc pyrithione 1 % Medicated ConditionerSY2
209884zinc pyrithione 1 % Medicated ShampooSY2

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
71141-027-042024-01-30C16284748780-11030e365-3b54-111a-e063-dadaa90a10e271141-027, LIDL US LLC

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
71141-027-042 in 1420 mL in 1 BOTTLE, PLASTICSHAMPOO4202

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
71141-0272 IN 1 (PYRITHIONE ZINC) SHAMPOO [LIDL US LLC]2Legacy NDC, 1 package rows20220913_cb03f641-6605-ec6f-e053-2995a90afa99.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 19 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
71141-02771141-027-04

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 18 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
e8741621-cd90-e478-e053-2995a90ac399cb03f641-6605-ec6f-e053-2995a90afa992022-09-12WarningsExact identifier
spl id: e8741621-cd90-e478-e053-2995a90ac399
spl set id: cb03f641-6605-ec6f-e053-2995a90afa99

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.